Log In
Print this Print this

Org 25935

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionGlycine transporter type 1 (GlyT1) inhibitor
Molecular Target Glycine transporter type 1 (GlyT1) (SLC6A9)
Mechanism of ActionGlycine transporter type 1 (GlyT1) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCognitive dysfunction
Indication DetailsTreat cognitive dysfunction
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today